SMS Pharmaceuticals wins order worth ₹7.19 crore

What happened

SMS Pharmaceuticals (SMSPHARMA) told the exchanges on 31 October 2026 at 08:24 PM that it has received an order valued at ₹7.19 crore.

From the filing: "the SEBI ( LODR ) Regulations, 2015 - Order received from the Income Tax Department."

How big is it?

At ₹7.19 crore, the order is equal to about 0.2% of the company's market value of ₹4,550 crore and 0.8% of its revenue over the last four reported quarters (₹898 crore).

Relative to the company's annual revenue, it is a modest addition.

Company snapshot

SMS Pharmaceuticals is a small-cap company, with a market value of about ₹4,550 crore.

The stock last traded at ₹485.8, against a 52-week range of ₹270.1–₹494.5 (1.8% below the high).

Before this filing the shares had moved +5.1% over the month and +29.7% over three months. Average daily turnover over the last 20 sessions was about ₹17.88 crore.

Promoters held 68.07% at the end of Q1 FY27; 17.99% of promoter shares were pledged. Foreign institutions owned 0.65% and domestic institutions 2.83%.

What history shows

This is not the company's first order win disclosure: BCEIE has 1 earlier filing of this kind on record since May 2026.

Market-wide, 2,100 order win filings with an impact score of 50 or more saw an average next-day move of +0.9%, with 54% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

• Execution progress and revenue recognition from this order in the coming quarters.
• 4 November 2026: Board meeting — Financial Results.

In the news

Recent coverage elsewhere (links open the original publisher):

• SMS Pharmaceuticals SMSPHARMA Income Tax Appeal Dismissed AY2018-19 — Kalkine India, 31 Oct 2026
• SMS Pharmaceuticals SMSPHARMA Rs 50 Crore Loan to Subsidiary — Kalkine India, 30 Oct 2026
• SMS Pharmaceuticals appeal leads to Rs.45.63 crores tax demand cancellation — Business Upturn, 31 Oct 2026

Source

• Exchange filing (PDF)